Skip to content
Live funding
↑Microbiotica €42.7M Series C round led by British Business Bank ↑Goodweek €10.7M funding round led by Adara Ventures ↑Qilimanjaro Quantum Tech €19.6M raises a Series A round ↑Ambio €5.1M Seed round led by Lifeline Ventures ↑Duvo €28.5M Series A round led by Balderton Capital ↑Salience Labs €111.4M Series B round led by Bullhound Capital ↑Wavo €10M funding round led by Eurazeo ↑Cofrai €2.6M funding round led by DFF Ventures ↑Undecimal Bio €16M Seed round led by 4BIO Capital ↑Obsero €1M Seed round led by SFC Capital ↑ParkMundo €2.3M Seed round led by Rabobank ↑Ubitium €12.5M Seed round led by Ibex Investors ↑Alchera Technologies €3.2M Seed round led by Maven Capital Partners ↑Sainaptic €1.2M funding round led by Brighteye Ventures ↑reebuild €3M Seed round led by Rise PropTech ↑Causa Prima €17.9M Seed round led by Base10 Partners ↑Affinity Labs €1.8M Pre-seed round led by Antler ↑Epyr €15M Series A round led by SlateVC ↑CarbonFarm €7M Series A round led by Colam Impact ↑CMR Surgical €358.1M funding round led by Stryker
Sesame Summit 2027
Sesamers
M12

M12

● Actively deploying Redmond, United States · Founded 2016

Investment thesis

M12 is Microsoft's venture capital fund, investing from seed through Series B in AI applications, security for AI, AI cloud infrastructure, AI data operations and models, and deep tech systems. Its strategy is tied closely to Microsoft, and portfolio companies gain connections, customer introductions and product benefits through the company. M12 has more than 140 active investments and over 50 exits, and runs a joint AI and developer tools effort with GitHub.

Past investments

Company Round Date Round size
etalytics Darmstadt, Germany Series A Oct 2025 €8M

Sesamers coverage

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.